ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BrickBio Inks ADC Co-Development Deal
January 07, 2021BrickBio, a company specializing in site-specific bioconjugation for improved therapeutics, has signed an agreement with a large pharmaceutical company to co-develop a therapeutic antibody drug conjugate (ADC). -
Abcam and BrickBio Announce a Partnership to Incorporate Conjugation-Ready Sites into Recombinant Antibodies Across Abcam’s Portfolio
November 12, 2019Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce a strategic partnership with BrickBio, experts in site-specific protein modification and a Tiger Gene portfolio company ...
Pharma Sources Insight January 2025
